2026 NPPES data Pharmacotherapy Pharmacist NPI 1265506943 PHARM. D.
Verify on CMS →

JOHN HYUN, PHARM. D.

Pharmacotherapy Pharmacist in RIVERSIDE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
623
Medicare Part D claims · 184 beneficiaries · Pharmacotherapy Pharmacist avg: 397
Generic prescribing
39%
generic claims · 61% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: JOHN HYUN, PHARM. D. is a Pharmacotherapy Pharmacist ([object Object]) practicing in RIVERSIDE, California with a Medicare Part D prescribing footprint of 623 claims across 184 beneficiaries — 61% brand-name prescribing .

What stands out: JOHN HYUN, PHARM. D. filed 623 Medicare Part D claims in 2023 across RIVERSIDE, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

JOHN HYUN, PHARM. D. at a glance

Quality data not reported

NPI registry status

Active

Issued 11/17/2006

NPI 1265506943

Primary specialty

Pharmacotherapy Pharmacist

Mid-sized

5,925 US NPIs in this specialty

Medicare Part D claims

623 57% vs specialty avg

2023 prescription claims

Specialty avg: 397

Specialty distribution in California

How Pharmacotherapy Pharmacist compares to other specialties among California providers

California providers

Pharmacotherapy Pharmacist share within California

1. Pharmacotherapy Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacotherapy Pharmacist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacotherapy Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacotherapy Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOHN HYUN, PHARM. D. is a Pharmacotherapy Pharmacist provider practicing in RIVERSIDE, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARM. D.. NPI: 1265506943. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JOHN HYUN, PHARM. D. appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding PHARM. D. credentials at 10800 MAGNOLIA AVE, RIVERSIDE, CA, 92505, with a listed phone of (951) 353-4059. NPI 1265506943 was issued on 11/17/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HYUN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 623 prescription claims written by this provider, covering 184 Medicare beneficiaries and totaling roughly $319K in drug spend, split 61% brand-name and 39% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

10800 MAGNOLIA AVE
RIVERSIDE, CA 92505

Provider Details

NPI 1265506943
Specialty Pharmacotherapy Pharmacist
Credentials PHARM. D.
Gender Male
NPI Issued 11/17/2006

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to JOHN HYUN, PHARM. D.. To verify JOHN HYUN, PHARM. D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

JOHN HYUN, PHARM. D. — brand share 61.0%
Specialty average (est.)

61% brand-name claims vs 39% generic, on 623 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

623
Total Claims
$319K
Total Drug Cost
184
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
778
Total Day Supply
22,308
Brand vs Generic
61% brand / 39% generic
Brand Drug Cost
$315K

Patient Demographics

Average Patient Age
73.8 years
Avg HCC Risk Score
4.14
Gender Split
54% female / 46% male
Age Distribution
<65: 30, 65-74: 56, 75-84: 66, 85+: 32

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Procrit
Epoetin Alfa
382
Alcohol Prep Pads
Alcohol Antiseptic Pads
24
Single Use Swab
Alcohol Antiseptic Pads
17
Veo Insulin Syringe
"Syringe And Needle
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacotherapy Pharmacist Overview

How JOHN HYUN, PHARM. D. fits within the Pharmacotherapy Pharmacist landscape nationally.

5,925
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
397
Avg Claims per Provider

JOHN HYUN, PHARM. D.'s 623 claims are above the specialty average of 397.

Nearby Pharmacotherapy Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as HYUN.

Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOHN HYUN, PHARM. D.'s specialty?
JOHN HYUN, PHARM. D. specializes in Pharmacotherapy Pharmacist and practices in RIVERSIDE, California. Credentials: PHARM. D..
How much does JOHN HYUN, PHARM. D. prescribe under Medicare Part D?
In 2023, JOHN HYUN, PHARM. D. wrote 623 Medicare Part D claims totaling $319K in drug costs for 184 beneficiaries.
Where is JOHN HYUN, PHARM. D. located?
JOHN HYUN, PHARM. D. is located at 10800 MAGNOLIA AVE, RIVERSIDE, CA, 92505. Phone: (951) 353-4059.
What is JOHN HYUN, PHARM. D.'s NPI number?
JOHN HYUN, PHARM. D.'s National Provider Identifier (NPI) is 1265506943, issued on 11/17/2006.
Does JOHN HYUN, PHARM. D. prescribe more brand-name or generic drugs?
JOHN HYUN, PHARM. D.'s prescribing is 61% brand-name and 39% generic drugs by claim count, with $315K in brand drug costs.
How many Pharmacotherapy Pharmacist providers are there in the US?
There are 5,925 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 397 Medicare Part D claims per year.
What drugs does JOHN HYUN, PHARM. D. prescribe most often?
Based on 2023 Medicare Part D data, JOHN HYUN, PHARM. D.'s most frequently prescribed drugs include Procrit, Alcohol Prep Pads, Single Use Swab. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOHN HYUN, PHARM. D. accept Medicare?
JOHN HYUN, PHARM. D. appears in CMS Medicare data with 623 Part D claims and 184 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOHN HYUN, PHARM. D.'s credentials?
JOHN HYUN, PHARM. D.'s NPI is 1265506943 with credentials PHARM. D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology